Entrada Therapeutics Inc. – Filings and Transcripts

NASDAQ: TRDA
Share price (6/11/26): $6.31
Market cap (6/11/26): $245 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Radhakrishnan Maha

News Filter

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Investor Presentation

Reports First Quarter 2026 Financial Results

Reports Fourth Quarter and Full Year 2025 Financial Results

Highlights Progress Across Its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Scanned paper annual report submission